Approval · Notice of Compliance 4095 · 1997
COPTIN: Notice of Compliance 4095
Issued November 17, 1997
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4095
- Date
- November 17, 1997
- Company
- Axcan Pharma Inc.Mont St-Hilaire, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Antibacterial
Products in this notice
Medicinal ingredients
- SULFADIAZINE 410 MG per TAB
- TRIMETHOPRIM 90 MG per TAB
- SULFADIAZINE 9 MG per ML
- TRIMETHOPRIM 41 MG per ML